Fetal membranes as a source of stem cells

Area of Science:

• Stem cell biology
• Regenerative medicine
• Tissue engineering

Background:

• Mesenchymal stem cells (MSCs) are valuable for research and therapy due to their differentiation potential.
• Bone marrow (BM) is a common MSC source but harvesting is invasive and yields decrease with age.
• Alternative, readily available MSC sources are needed.

Purpose of the Study:

• To review the biology and characteristics of stem cells from human fetal membranes (amnion and chorion).
• To explore the potential clinical applications of these placental-derived MSCs.
• To highlight placental stem cells as a viable alternative to bone marrow-derived MSCs.

Main Methods:

• Literature review focusing on stem cell biology and clinical applications.
• Analysis of studies on mesenchymal stem cells derived from human placenta.
• Examination of differentiation capabilities and paracrine effects of placental MSCs.

Main Results:

• Human placenta is a rich source of stem cells that proliferate and differentiate in vitro.
• Placental stem cells exhibit homing and differentiation at injury sites.
• MSCs from fetal membranes exert paracrine effects that stimulate tissue repair.

Conclusions:

• Human fetal membranes (amnion and chorion) provide a promising, non-invasive source of mesenchymal stem cells.
• Placental MSCs hold significant potential for diverse therapeutic applications in regenerative medicine.
• Further research into placental stem cells can advance clinical treatments and reduce reliance on invasive harvesting methods.